Literature DB >> 24867787

HIV and hepatitis C virus infection in the United States: whom and how to test.

Nivedha Panneer1, Erik Lontok1, Bernard M Branson2, Chong-Gee Teo3, Corinna Dan4, Monica Parker5, Joanne D Stekler6, Alfred DeMaria7, Veronica Miller1.   

Abstract

In the United States, of the 1.1 million persons infected with human immunodeficiency virus (HIV) and the 2.7 million infected with hepatitis C virus (HCV), approximately 16% and 50%, respectively, are unaware of their infection. Highly effective treatments have turned both diseases into manageable conditions, and in the case of hepatitis C, a disease that can be cured. Early diagnosis is imperative so that infected persons can take measures to stay healthy, get into care, benefit from therapy, and reduce the risk of transmission. In this report, we review current recommendations provided by the Centers for Disease Control and Prevention (CDC) and the United States Preventive Services Task Force on whom to screen for HIV and HCV infections, and recommendations from the CDC, the Association of Public Health Laboratories, and the Clinical and Laboratory Standards Institute on how to test for these infections.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCV; HIV; hepatitis C virus; nucleic acid test; testing algorithm

Mesh:

Year:  2014        PMID: 24867787     DOI: 10.1093/cid/ciu396

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

2.  Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR.

Authors:  Geetaram Sahu; Kalamo Farley; Nazira El-Hage; Benjamas Aiamkitsumrit; Ryan Fassnacht; Fatah Kashanchi; Alex Ochem; Gary L Simon; Jonathan Karn; Kurt F Hauser; Mudit Tyagi
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

3.  Doubling Hepatitis C Virus Screening in Primary Care Using Advanced Electronic Health Record Tools-A Non-Randomized Controlled Trial.

Authors:  Leila Hojat; Ann Avery; Peter J Greco; David C Kaelber
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

4.  Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.

Authors:  Eshan U Patel; Andrea L Cox; Shruti H Mehta; Denali Boon; Caroline E Mullis; Jacquie Astemborski; William O Osburn; Jeffrey Quinn; Andrew D Redd; Gregory D Kirk; David L Thomas; Thomas C Quinn; Oliver Laeyendecker
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

5.  Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in Nigeria.

Authors:  Mark M Manak; Ogbonnaya S Njoku; Ashley Shutt; Jennifer Malia; Linda L Jagodzinski; Mark Milazzo; Aminu Suleiman; Amos A Ogundeji; Robert Nelson; Ojor R Ayemoba; Robert J O'Connell; Darrell E Singer; Nelson L Michael; Sheila A Peel
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

6.  Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.

Authors:  César Garriga; Sandra Manzanares-Laya; Patricia García de Olalla; Pilar Gorrindo; Sabela Lens; Ricard Solà; María Martínez-Rebollar; Montserrat Laguno; Jordi Navarro; Xavier Torras; Mercè Gurguí; María-Jesús Barberá; Josep Quer; Eva Masdeu; Pere Simón; Miriam Ros; Anna de Andrés; Joan A Caylà
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

7.  Management of Cytomegalovirus, Epstein-Barr Virus, and HIV Viral Load Quality Control Data Using Unity Real Time.

Authors:  Duane W Newton; Nico Vandepoele; John C Yundt-Pacheco; David Gauthier; Michael A Bachman
Journal:  J Clin Microbiol       Date:  2021-10-20       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.